您的购物车当前为空
CBL 0100 free base是一种HIV-1转录抑制剂,在体外和离体模型中阻断HIV-1复制和再激活,靶向促进染色质转录(FACT)复合物,降低RNA Polymerase II和FACT在HIV-1启动子区域的占用,可以作为潜伏期促进剂(LRAs)用于cART疗法。
别名 Curaxin 100, CBL0100 free base, CBL 0100 free base, 6-[2-(Diethylamino)ethyl]-10,11-dihydro-1H-dicyclopenta[c,g]carbazole-3,9(2H,6H)-dione (ACI), 1H-Dicyclopenta[c,g]carbazole-3,9(2H,6H)-dione, 6-[2-(diethylamino)ethyl]-10,11-dihydro- (ACI)
CBL 0100 free base是一种HIV-1转录抑制剂,在体外和离体模型中阻断HIV-1复制和再激活,靶向促进染色质转录(FACT)复合物,降低RNA Polymerase II和FACT在HIV-1启动子区域的占用,可以作为潜伏期促进剂(LRAs)用于cART疗法。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,330 | 现货 | |
| 5 mg | ¥ 5,630 | 现货 | |
| 10 mg | ¥ 7,880 | 现货 | |
| 25 mg | ¥ 11,600 | 现货 | |
| 50 mg | ¥ 15,700 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | CBL 0100 free base is an HIV-1 transcription inhibitor that blocks HIV-1 replication and reactivation in vitro and in ex vivo models. It targets the chromatin-associated transcription (FACT) complex, reducing the occupancy of RNA Polymerase II and FACT in the HIV-1 promoter region, and can be used as a latency-reversing agent (LRA) in cART therapy. |
| 体外活性 | CBL 0100 free base(0.1μM)处理J-LAT A1和A2细胞,可以导致J-LAT A1和A2细胞中的GFP +细胞群和GFP平均荧光强度(MFI)均降低,而没有任何细胞毒性。[1] |
| 别名 | Curaxin 100, CBL0100 free base, CBL 0100 free base, 6-[2-(Diethylamino)ethyl]-10,11-dihydro-1H-dicyclopenta[c,g]carbazole-3,9(2H,6H)-dione (ACI), 1H-Dicyclopenta[c,g]carbazole-3,9(2H,6H)-dione, 6-[2-(diethylamino)ethyl]-10,11-dihydro- (ACI) |
| 分子量 | 374.48 |
| 分子式 | C24H26N2O2 |
| CAS No. | 1197996-83-0 |
| Smiles | O=C1C2=CC=C3C(C=4C(=CC=C5C(=O)CCC54)N3CCN(CC)CC)=C2CC1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多